What is the recommended dosage and treatment duration for iron deficiency using FeO (Ferrous Oxide) spansule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

FeO Spansule for Iron Deficiency: Dosing and Duration

For iron deficiency anemia, start with ferrous sulfate 200 mg once daily (or every other day if not tolerated), and continue treatment for 3 months after hemoglobin normalizes to replenish iron stores. 1

Initial Treatment Approach

Ferrous sulfate remains the gold standard for oral iron therapy due to its optimal absorption, efficacy, and cost-effectiveness. 1, 2, 3 While you asked about ferrous oxide (FeO) spansules specifically, current guidelines prioritize standard ferrous sulfate formulations over modified-release preparations.

Recommended Dosing Strategy

  • Start with 50-100 mg elemental iron once daily (ferrous sulfate 200 mg contains 65 mg elemental iron). 1
  • Once-daily dosing is as effective as multiple daily doses because iron absorption triggers hepcidin elevation, which reduces subsequent iron absorption by 35-45% when taken more frequently. 1
  • Alternate-day dosing may be considered if daily dosing is not tolerated, as this significantly increases fractional iron absorption. 1

Treatment Duration

  • Continue oral iron for approximately 3 months after hemoglobin normalizes to ensure adequate repletion of marrow iron stores. 1
  • Monitor hemoglobin response within the first 4 weeks to confirm treatment effectiveness. 1
  • Expect hemoglobin to rise by 2 g/dL after 3-4 weeks of appropriate therapy. 1

Important Caveats About Modified-Release Formulations

Modified-release (MR) or "spansule" formulations are generally not recommended as first-line therapy. 1 These preparations:

  • Release iron beyond the duodenum where absorption is optimal
  • Are more expensive than standard ferrous sulfate tablets
  • Have not demonstrated superior efficacy in clinical guidelines 1

Alternative Options if Standard Therapy Fails

If ferrous sulfate is not tolerated at standard doses:

  • Reduce to one tablet every other day before switching formulations. 1
  • Consider alternative ferrous salts (ferrous fumarate 210 mg or ferrous gluconate 300 mg). 1
  • Ferric maltol (30 mg twice daily) may be better tolerated in patients with previous intolerance to traditional iron salts. 1

When to Consider Parenteral Iron

Switch to intravenous iron when oral iron is contraindicated, ineffective, or not tolerated after trying at least two oral preparations. 1 Specific indications include:

  • Intolerance to oral iron despite dose reduction or formulation changes 1, 3
  • Inadequate response to oral therapy 4, 3
  • Active inflammatory bowel disease with compromised absorption 4, 3
  • Chronic kidney disease or heart failure 4, 3
  • Need for rapid iron repletion (e.g., pre-operative) 5, 3
  • Hemoglobin below 10 g/dL requiring faster correction 4

Follow-Up Monitoring

After successful iron repletion:

  • Monitor blood count every 3-6 months initially for the first year to detect recurrent iron deficiency. 1
  • Re-check after another year if stable. 1, 4
  • Give additional oral iron if hemoglobin or MCV falls below normal during follow-up. 1

Common Pitfalls to Avoid

  • Don't use multiple daily doses as first-line strategy—once daily or alternate-day dosing optimizes absorption and tolerability. 1
  • Don't stop treatment when hemoglobin normalizes—continue for 3 additional months to replenish stores. 1
  • Don't assume treatment failure before 3-4 weeks—allow adequate time for hemoglobin response. 1
  • Don't persist with poorly tolerated oral iron—consider dose reduction, alternate-day dosing, or parenteral iron rather than accepting non-compliance. 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Iron Deficiency Anemia Treatment with Ferric Derisomaltose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral and Intravenous Iron Therapy.

Advances in experimental medicine and biology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.